Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
Researchers are trying to identify predictors for gastroesophageal reflux disease after sleeve gastrectomy.
Eligibility criteria
Qualifiers
Adult patients > 18 years
BMI 30 or greater kg/m2
Participants can give a consent to the procedure
Participants have no contraindications to LSG (gastric ulceration)
Disqualifiers
Participants who have LA grade C or D esophagitis, Barrett mucosa or peptic stricture.
Patients who have evidence of a major motility abnormality defined by the Chicago classification version 3.0 (achalasia, absent contractility, esophagogastric junction outflow obstruction, distal esophageal spasm, or hypertensive peristalsis)
Patients with hiatal hernia > 3 cm
Patients with previous esophageal or stomach surgery
Trial design
Treatments tested in this trial
- EndoFLIP measurement
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov